Literature DB >> 18445337

Interleukin-7 receptor signaling network: an integrated systems perspective.

Megan J Palmer1, Vinay S Mahajan, Lily C Trajman, Darrell J Irvine, Douglas A Lauffenburger, Jianzhu Chen.   

Abstract

Interleukin-7 (IL-7) is an essential cytokine for the development and homeostatic maintenance of T and B lymphocytes. Binding of IL-7 to its cognate receptor, the IL-7 receptor (IL-7R), activates multiple pathways that regulate lymphocyte survival, glucose uptake, proliferation and differentiation. There has been much interest in understanding how IL-7 receptor signaling is modulated at multiple interconnected network levels. This review examines how the strength of the signal through the IL-7 receptor is modulated in T and B cells, including the use of shared receptor components, signaling crosstalk, shared interaction domains, feedback loops, integrated gene regulation, multimerization and ligand competition. We discuss how these network control mechanisms could integrate to govern the properties of IL-7R signaling in lymphocytes in health and disease. Analysis of IL-7 receptor signaling at a network level in a systematic manner will allow for a comprehensive approach to understanding the impact of multiple signaling pathways on lymphocyte biology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445337      PMCID: PMC2763551          DOI: 10.1038/cmi.2008.10

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  41 in total

1.  Ephrinb1 and Ephrinb2 are associated with interleukin-7 receptor α and retard its internalization from the cell surface.

Authors:  Hongyu Luo; Zenghui Wu; Shijie Qi; Wei Jin; Bing Han; Jiangping Wu
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.

Authors:  Brian R Lawson; Rosana Gonzalez-Quintial; Theodoros Eleftheriadis; Michael A Farrar; Stephen D Miller; Karsten Sauer; Dorian B McGavern; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2015-08-25       Impact factor: 3.969

3.  Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.

Authors:  Yrina Rochman; Mohit Kashyap; Gertraud W Robinson; Kazuhito Sakamoto; Julio Gomez-Rodriguez; Kay-Uwe Wagner; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension.

Authors:  Michael G Risbano; Christina A Meadows; Christopher D Coldren; Tiffany J Jenkins; Michael G Edwards; David Collier; Wendy Huber; Douglas G Mack; Andrew P Fontenot; Mark W Geraci; Todd M Bull
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

5.  Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.

Authors:  Christian M Capitini; Terry J Fry; Crystal L Mackall
Journal:  Am J Immunol       Date:  2009-01-01

6.  Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent.

Authors:  C Bryce Johnson; Brian P Riesenberg; Bennett R May; Stuart C Gilreath; Guangfu Li; Kevin F Staveley-O'Carroll; Elizabeth Garrett-Mayer; Shikhar Mehrotra; David J Cole; Mark P Rubinstein
Journal:  Cancer Immunol Res       Date:  2015-08-21       Impact factor: 11.151

Review 7.  The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease.

Authors:  Stewart Leung; Xuebin Liu; Lei Fang; Xi Chen; Taylor Guo; Jingwu Zhang
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

8.  BCL6 is critical for the development of a diverse primary B cell repertoire.

Authors:  Cihangir Duy; J Jessica Yu; Rahul Nahar; Srividya Swaminathan; Soo-Mi Kweon; Jose M Polo; Ester Valls; Lars Klemm; Seyedmehdi Shojaee; Leandro Cerchietti; Wolfgang Schuh; Hans-Martin Jäck; Christian Hurtz; Parham Ramezani-Rad; Sebastian Herzog; Hassan Jumaa; H Phillip Koeffler; Ignacio Moreno de Alborán; Ari M Melnick; B Hilda Ye; Markus Müschen
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

Review 9.  Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Authors:  C M Capitini; A A Chisti; C L Mackall
Journal:  J Intern Med       Date:  2009-08       Impact factor: 8.989

10.  Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?

Authors:  Hua-xia Yang; Wen Zhang; Li-dan Zhao; Yang Li; Feng-chun Zhang; Fu-lin Tang; Wei He; Xuan Zhang
Journal:  Arthritis Res Ther       Date:  2009-10-12       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.